Postoperative Physical Therapy Program Focused on Low Back Pain Can Improve Treatment Satisfaction after Minimally Invasive Lumbar Decompression.
Hidetomi TeraiKoji TamaiKunikazu KanedaToshimitsu OhmineHiroshi KatsudaNagakazu ShimadaYuto KobayashiHiroaki NakamuraPublished in: Journal of clinical medicine (2022)
Patient satisfaction is crucial in pay-for-performance initiatives. To achieve further improvement in satisfaction, modifiable factors should be identified according to the surgery type. Using a prospective cohort, we compared the overall treatment satisfaction after microendoscopic lumbar decompression between patients treated postoperatively with a conventional physical therapy (PT) program (control; n = 100) and those treated with a PT program focused on low back pain (LBP) improvement (test; n = 100). Both programs included 40 min outpatient sessions, once per week for 3 months postoperatively. Adequate compliance was achieved in 92 and 84 patients in the control and test cohorts, respectively. There were no significant differences in background factors; however, the patient-reported pain score at 3 months postoperatively was significantly better, and treatment satisfaction was significantly higher in the test than in the control cohort (-0.02 ± 0.02 vs. -0.03 ± 0.03, p = 0.029; 70.2% vs. 55.4%, p = 0.045, respectively). In the multivariate logistic regression analysis, patients treated with the LBP program tended to be more satisfied than those treated with the conventional program, independent of age, sex, and diagnosis (adjusted odds ratio = 2.34, p = 0.012). Postoperative management with the LBP program could reduce pain more effectively and aid spine surgeons in achieving higher overall satisfaction after minimally invasive lumbar decompression, without additional pharmacological therapy.
Keyphrases
- minimally invasive
- quality improvement
- robot assisted
- patient reported
- chronic pain
- patient satisfaction
- clinical trial
- end stage renal disease
- patients undergoing
- public health
- randomized controlled trial
- combination therapy
- coronary artery disease
- ejection fraction
- acute coronary syndrome
- mesenchymal stem cells
- spinal cord
- health insurance
- bone marrow
- replacement therapy
- percutaneous coronary intervention
- coronary artery bypass
- atrial fibrillation